Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

This study has been completed.
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00078143
First received: February 19, 2004
Last updated: April 13, 2010
Last verified: April 2010
  Purpose

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.


Condition Intervention Phase
Substance-Related Disorders
Behavioral: Behavior Therapy
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Treatment Utilization
  • Substance Abuse

Estimated Enrollment: 200
Study Start Date: October 2003
Study Completion Date: April 2006
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pregnancy <30 weeks
  • Have not attended drug treatment in past 28 days
  • Not needing residential treatment (except detox)
  • Not at risk for suicide/homicide
  • Have no pending legal charges (except drug treatment)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00078143

Locations
United States, Indiana
Midtown Community Mental Health Center
Indianapolis, Indiana, United States, 46202
United States, Kentucky
Jefferson Alcohol & Drug Abuse Center
Louisville, Kentucky, United States, 40202
United States, Michigan
Eleonore Hutzel Recovery Center
Detroit, Michigan, United States, 48201
United States, New Mexico
Milagro Clinic
Albuquerque, New Mexico, United States, 87106
Milagro
Albuquerque, New Mexico, United States, 87106
United States, North Carolina
Coastal Horizons Center, Inc.
Wilmington, North Carolina, United States, 28412
Sponsors and Collaborators
University of Cincinnati
Investigators
Principal Investigator: Theresa Winhusen, Ph.D. University of Cincinnati
  More Information

No publications provided

Responsible Party: Theresa Winhusen, Ph.D., University of Cincinnati
ClinicalTrials.gov Identifier: NCT00078143     History of Changes
Other Study ID Numbers: NIDA-CTN-0013-1
Study First Received: February 19, 2004
Last Updated: April 13, 2010
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014